AstraZeneca PLC (AZN.L)
LSE - LSE Delayed price. Currency in GBp
Add to watchlist
9,013.00+71.00 (+0.79%)
As of 11:00AM BST. Market open.
Loading interactive chart…
- Business Wire
IMFINZI Plus Chemotherapy Significantly Improved Overall Survival in 1st-Line Advanced Biliary Tract Cancer in TOPAZ-1 Phase III Trial at Interim Analysis
WILMINGTON, Del., October 25, 2021--Positive high-level results from the TOPAZ-1 Phase III trial showed IMFINZI® (durvalumab), in combination with standard-of-care chemotherapy, demonstrated a statistically significant and clinically meaningful overall survival (OS) benefit versus chemotherapy alone as a 1st-line treatment for patients with advanced biliary tract cancer (BTC).
- The Telegraph
Winners of the WorkL Workplace Awards 2021 revealed
AstraZeneca, Boeing and Openreach are among Britain’s best places to work, according to the WorkL Workplace Awards 2021.
- The Telegraph
The bold bet that reversed the fortunes of Oxford vaccine manufacturer
The gleaming white table in the boardroom of Oxford Biomedica’s headquarters is so enormous and heavy it can only be removed by taking down the windows and lifting it with a crane. The carpet feels soft, squishy – expensive.
© 2021 Verizon Media. All rights reserved.
